# Does Oklahoma Medicaid Cover Wegovy? SoonerCare's GLP-1 Rules for 2026 By Nora Bissett, Pricing Editor (https://glpwatchdog.org/authors/nora-bissett) | Published: 2026-11-06 Canonical page: https://glpwatchdog.org/research/oklahoma-medicaid-glp1-coverage > Oklahoma's SoonerCare excludes drugs whose only use is weight management, yet approves Wegovy for heart risk from age 45 or MASH, and Zepbound for sleep apnea, with no diabetes allowed. Criteria, the eight-week dose approvals, Ozempic's tier and appeals. ## Key points - SoonerCare excludes drugs used only for weight management, including Saxenda and orlistat. - Wegovy for heart risk needs an adult of 45 or more with a BMI from 27, current heart treatment and an A1c under 6.5%. - Zepbound for sleep apnea needs an AHI from 15 up and a BMI from 30 up, with no CPAP trial. - No route accepts members who have either type of diabetes, and each titration dose is approved eight weeks at a time. - Ozempic is a Tier 3 diabetes drug, after metformin and Trulicity or Victoza. Not for weight loss. As of November 2026, SoonerCare, Oklahoma’s Medicaid program, treats drugs used only for chronic weight management as a coverage exclusion, but it pays for Wegovy to lower heart risk or treat the liver disease MASH, and for Zepbound to treat sleep apnea, with prior authorization.[2] All three routes are closed to anyone who has type 1 or type 2 diabetes, and the heart and sleep apnea routes also require an A1c under 6.5%.[1] > **About this article.** This page reads the Oklahoma Health Care Authority’s drug review board packets from March 11 and August 12, 2026, the state’s current prior authorization criteria, the SoonerCare Wegovy and Zepbound request forms dated August 31, 2026, and the state’s diabetes drug tiers, as they stood on November 6, 2026. We could not open the state’s appeal rule for fee-for-service members. To compare states, use the [state Medicaid GLP-1 checker](https://glpwatchdog.org/tools/state-medicaid-glp1-checker). ## Does SoonerCare cover Wegovy for weight loss? No. In its August 2026 review, the state said medicines whose only FDA use is chronic weight management, such as Saxenda, are a coverage exclusion, and that drugs used mainly to treat obesity are not covered.[2] That shuts out orlistat as well, which had no SoonerCare claims in fiscal 2025.[2] Federal law gives every state this option.[9] Our explainer on [why Medicaid covers Ozempic but not Wegovy for weight](https://glpwatchdog.org/research/does-medicaid-cover-ozempic-and-wegovy) sets out the federal rule, and the [Medicaid coverage hub](https://glpwatchdog.org/insurance/medicaid) compares programs. The three label uses are a small program. During fiscal 2025, 150 SoonerCare members had paid claims for Wegovy or Zepbound, 390 claims in all.[2] The SoonerSelect health plans (Aetna Better Health of Oklahoma, Humana Healthy Horizons and Oklahoma Complete Health) follow the state’s clinical criteria for drugs that need review, so the rules below apply whichever plan a member has.[6] ## When will Oklahoma Medicaid pay for Wegovy or Zepbound? *SoonerCare GLP-1 routes outside diabetes, from criteria approved March 11, 2026* | Use | Drug | Age | Main requirements | | --- | --- | --- | --- | | Weight loss alone | Any | Any | Not covered | | Lowering heart attack and stroke risk | Wegovy injection or tablets | 45 or older | Prior heart attack, prior stroke or leg artery disease with symptoms; BMI 27 or more; on heart medicines; no diabetes; A1c under 6.5% | | MASH with F2 to F3 fibrosis | Wegovy injection | 18 or older | FibroScan, ELF test or biopsy result; GI doctor or liver specialist; no diabetes; no A1c limit listed | | Moderate to severe sleep apnea | Zepbound pens or KwikPen | 18 or older | AHI 15 or more on a lab or home test; BMI 30 or more; no central or mixed apnea; no diabetes; A1c under 6.5% | The no-diabetes rule is the detail that trips people up. It appears in every route, and renewals ask again whether the member has developed diabetes.[1] Someone with type 2 diabetes goes through the diabetes drug list instead, described below. ## What does SoonerCare require for Wegovy and heart disease? The member must be 45 or older with a documented prior heart attack, prior stroke, or leg artery disease with symptoms, shown by claudication with an ankle-brachial index under 0.85, an artery procedure or an amputation from atherosclerosis.[1] The BMI must be at least 27, and the A1c under 6.5%.[1] The member must already be on guideline-directed heart treatment, such as blood pressure, cholesterol or antiplatelet drugs, as shown in pharmacy claims, and the request must include office notes on the diet and exercise plan.[1] The age floor goes beyond the label, which covers adults with established heart disease and either obesity or overweight and names no minimum age.[11] Both the Wegovy injection and the Wegovy pill can be approved on this route; maintenance is 1.7 or 2.4 mg for the injection and 25 mg for the tablet.[1] ## Does Oklahoma Medicaid cover Wegovy for fatty liver disease? Yes, for noncirrhotic MASH with F2 or F3 fibrosis in adults. The request must include one of three test results: a FibroScan with liver stiffness of at least 8 kPa and a CAP score of at least 280, an ELF score of 9 or more, or a biopsy showing F2 or F3 fibrosis.[1] The member cannot have another chronic liver disease or diabetes, and a gastroenterologist or hepatologist must prescribe or consult.[1] The FDA approved this use on an accelerated basis.[11] Our page on [semaglutide for MASH](https://glpwatchdog.org/research/glp1-and-fatty-liver-mash) covers the evidence. ## Does SoonerCare cover Zepbound for sleep apnea, and is CPAP required? For adults whose sleep apnea is moderate or severe and who also have obesity, Zepbound is covered, and the criteria set no CPAP trial.[1] The request needs an AHI of 15 or more from a lab study or a home sleep test, a BMI of at least 30, no central or mixed sleep apnea, no diabetes and an A1c under 6.5%.[1] That tracks the label closely.[10] On the current Zepbound request form, only a vial needs a patient-specific reason the member cannot use a pen.[4] A member who cannot reach at least 5 mg will not be continued.[1] Renewal at maintenance, 5 to 15 mg, lasts a year and needs a record of better sleep apnea, such as less daytime sleepiness, a partner reporting less snoring or fewer pauses, or fewer AHI events.[1] Our guide to [Zepbound for sleep apnea](https://glpwatchdog.org/research/zepbound-for-sleep-apnea) covers the trials behind it. ## Why does SoonerCare approve one dose at a time? During the build-up, each dose needs its own prior authorization request.[1] In March 2026 the review board lengthened each of those approvals from four weeks to eight, after hearing that delays were holding up the titration.[1] If side effects make a step hard, another eight weeks at that dose can be approved with documentation.[1] Once the member reaches maintenance, approvals run for a year.[1] Prescribers should send the next dose request well before the current approval runs out so the pharmacy does not stall a refill. ## Does SoonerCare cover Ozempic for diabetes? Yes, but Ozempic is not first in line. On the state’s diabetes list, Trulicity and brand Victoza are Tier 2, Ozempic and Rybelsus are Tier 3, and Mounjaro needs a special prior authorization.[5] A Tier 2 drug needs a three-month metformin trial or a reason metformin will not work; Tier 3 needs a three-month trial of a Tier 2 drug in the same class that failed.[5] Every GLP-1 request at the special level must include the current and goal A1c.[5] Neighboring [Texas Medicaid’s GLP-1 rules](https://glpwatchdog.org/research/texas-medicaid-glp1-coverage) make a useful comparison. ## How do you request prior authorization or appeal in Oklahoma? Prescribers use form PHARM-277 for Wegovy and PHARM-316 for Zepbound, both revised August 31, 2026, and fax them to the University of Oklahoma College of Pharmacy’s Pharmacy Management Consultants at 1-800-224-4014; the phone line is 1-800-522-0114, option 4.[3][4] A SoonerSelect member appeals to the plan first, by phone or in writing, within 60 days of the denial notice.[7] If the plan upholds it, form LD-1S requests a state fair hearing, with a 120-day limit counted from the plan’s adverse benefit determination notice.[8] A denial for a missing A1c, sleep study or FibroScan result is usually fixed by resubmitting; one based on a diabetes diagnosis follows the written criteria.[1] Our guide to [prior authorization and appeals](https://glpwatchdog.org/research/glp1-prior-authorization-and-appeals) covers what to include. ## What are the options if SoonerCare says no? Paying cash, without the manufacturer card: Lilly’s Zepbound savings terms exclude Medicaid enrollees.[12] In the prices we track, Novo Nordisk sells most Wegovy pen doses for $349 a month, and Lilly’s self-pay Zepbound costs $299 at the starting dose, $399 at 5 mg and $449 at 7.5 mg and up when each refill comes within 45 days.[12][13] Our list of the [cheapest GLP-1 options without insurance](https://glpwatchdog.org/research/cheapest-glp1-without-insurance) compares them. ## Frequently asked questions ### Does Oklahoma Medicaid cover Wegovy? Not for weight loss. As of November 2026, SoonerCare covers Wegovy with prior authorization for adults 45 and older who already have heart disease and a BMI at or above 27, and for adults with MASH and F2 to F3 fibrosis, in both cases only without diabetes. ### Does SoonerCare cover Zepbound? Only for moderate to severe sleep apnea. The member must be an adult with an AHI of 15 or more, a BMI of at least 30, no diabetes and an A1c under 6.5%. No CPAP trial is required. ### Can I get Wegovy or Zepbound through SoonerCare if I have type 2 diabetes? No. All three SoonerCare routes for Wegovy and Zepbound exclude members with type 1 or type 2 diabetes. People with diabetes use the diabetes drug list, where Trulicity and Victoza come before Ozempic and Mounjaro. ### Does SoonerCare cover Ozempic? Yes, for type 2 diabetes, as a Tier 3 drug. It generally needs a failed three-month trial of Trulicity or Victoza first, which in turn follows a metformin trial or a reason metformin cannot be used. ### How long does a SoonerCare Wegovy approval last? Each dose during the build-up is approved for eight weeks at a time. Once the member reaches the maintenance dose, approvals run for one year if the member tolerates it and still has no diabetes. ### How long do I have to request a state fair hearing in Oklahoma? SoonerSelect members first appeal to their plan within 60 days. After that, form LD-1S says a state fair hearing request is due within 120 days of the date on the adverse benefit determination notice. ## References 1. Oklahoma Health Care Authority, Drug Utilization Review Board Meeting packet, March 11, 2026: Zepbound prior authorization and updated Wegovy criteria. oklahoma.gov. 2026. https://oklahoma.gov/content/dam/ok/en/okhca/docs/about/boards-and-committees/dur/2026/march/03112026%20DUR%20Packet.pdf 2. Oklahoma Health Care Authority, Drug Utilization Review Board Packet, August 12, 2026: FDA safety updates and SoonerCare actions. oklahoma.gov. 2026. https://oklahoma.gov/content/dam/ok/en/okhca/docs/about/boards-and-committees/dur/2026/august/08122026%20DUR%20Packet.pdf 3. Oklahoma Health Care Authority SoonerCare Wegovy (semaglutide) Prior Authorization Form, Pharm-277 (August 31, 2026). oklahoma.gov. 2026. https://oklahoma.gov/content/dam/ok/en/okhca/docs/providers/types/pharmacy/forms/2026/09.2026%20-%20PHARM%20-%20277.pdf 4. Oklahoma Health Care Authority SoonerCare Zepbound (tirzepatide) Prior Authorization Form, Pharm-316 (August 31, 2026). oklahoma.gov. 2026. https://oklahoma.gov/content/dam/ok/en/okhca/docs/providers/types/pharmacy/forms/2026/09.2026%20-%20PHARM%20-%20316.pdf 5. Oklahoma Health Care Authority Pharmacy prior authorization criteria 2026: Endocrine/Diabetics. oklahoma.gov. 2026. https://oklahoma.gov/ohca/providers/types/pharmacy/prior-authorization/2026/endocrine-diabeticse.html 6. Oklahoma Health Care Authority SoonerSelect Mental Health Parity and Addiction Equity Act report. oklahoma.gov. 2024. https://www.oklahoma.gov/content/dam/ok/en/okhca/docs/research/data-and-reports/studies-and-evaluations/2025/SoonerSelect%20MHPAEA%20Report-final%204.15.2024%20-CLEAN.pdf 7. Code of Federal Regulations 42 CFR §438.402: General requirements (managed care grievances and appeals). Legal Information Institute, Cornell Law School. 2026. https://www.law.cornell.edu/cfr/text/42/438.402 8. Oklahoma Health Care Authority Form LD-1S: Request for State Fair Hearing. oklahoma.gov. 2024. https://oklahoma.gov/content/dam/ok/en/okhca/docs/providers/forms/LD-1S%20-%20Request%20State%20Fair%20Hearing.pdf 9. United States Code 42 U.S.C. §1396r-8: Payment for covered outpatient drugs (Social Security Act §1927). Legal Information Institute, Cornell Law School. 2026. https://www.law.cornell.edu/uscode/text/42/1396r-8 10. Eli Lilly and Company ZEPBOUND (tirzepatide) injection: prescribing information. DailyMed. 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b 11. Novo Nordisk WEGOVY (semaglutide) injection and tablets: prescribing information. DailyMed. 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b 12. Eli Lilly and Company Zepbound savings and self-pay options, with card terms. zepbound.lilly.com. 2026. https://zepbound.lilly.com/savings 13. Novo Nordisk Wegovy savings offer. novocare.com. 2026. https://www.novocare.com/obesity/products/wegovy/savings-offer.html --- Cite as: GLP Watchdog, Nora Bissett, "Does Oklahoma Medicaid Cover Wegovy? SoonerCare's GLP-1 Rules for 2026", published 2026-11-06. https://glpwatchdog.org/research/oklahoma-medicaid-glp1-coverage Canonical HTML page: https://glpwatchdog.org/research/oklahoma-medicaid-glp1-coverage Medical disclaimer: Nothing here is medical advice. We report on this subject; we do not treat anyone. Whether to begin a medication, supplement, or treatment, whether to adjust it, and whether to stop are questions for a clinician licensed to answer them, who knows your history.